NCT00579475View on ClinicalTrials.gov

The Effect of Mifepristone on Uterine Fibroids and Breast Tissue

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Uterine Fibroids
Interventions
DRUG

Mifegyne

tablets, 50 mg every other day

DRUG

placebo

Trial Locations (1)

SE17176

Dept of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT00579475 - The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | Biotech Hunter | Biotech Hunter